SMAD3 and breast carcinoma: Moreover, according to our results, SMAD3 and SMAD7 are predicted targets of miR‐195‐5p, and their altered expression is associated with epithelial‐to‐mesenchymal transition (EMT) in breast carcinoma, as reported in previous studies [28, 50].